Along with the expression of regulatory cytokine IL-10, HMOX-1 encoding for HO-1 was reduced in monocytic MDSCs of secondary progressive multiple sclerosis (MS) patients when compared to relapsing–remitting MS patients or healthy subjects (83). This evidence concerns the gene HMOX1 and myeloid sarcoma.